Tonix Pharmaceuticals, Inc.
Clinical trials sponsored by Tonix Pharmaceuticals, Inc., explained in plain language.
A biopharmaceutical company developing therapies for central nervous system disorders and other conditions.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New immune drug TNX-1500 tested for safety in first human study
Knowledge-focused CompletedThis early-stage trial tested the safety of a new drug called TNX-1500 in 26 healthy adults. Participants received either a single dose of the drug or a placebo. The goal was to see if the drug is safe and how the body processes it, not to treat any disease. This is a first step …
Phase: PHASE1 • Sponsor: Tonix Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Muscle relaxant study in asian volunteers – no cure, just data
Knowledge-focused CompletedThis early-stage study gave 20 healthy Japanese and Chinese adults a single dose of TNX-102 SL (a cyclobenzaprine tablet placed under the tongue) to see how the drug moves through their bodies. Researchers compared two doses and checked safety. The goal was only to gather informa…
Phase: PHASE1 • Sponsor: Tonix Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC